Vividion Therapeutics, Inc.
4 clinical trials · Sponsor
◉ Watch Vividion Therapeutics, Inc.
| Record | Firm | Date |
|---|---|---|
| A First-in-Human (FIH) Study to Evaluate the Safety and Tolerability of VVD-159642 in Participants With Advanced Solid Tumors (NCT06804824) | Vividion Therapeutics, Inc. | 2025-02-25 |
| A Study to Evaluate the Safety, Pharmacokinetics, and Anti-Tumor Activity of VVD-133214 as Monotherapy and in Combination in Participants With Advanced Solid Tumors (NCT06004245) | Vividion Therapeutics, Inc. | 2024-01-25 |
| A First-in-Human (FIH) Study to Evaluate the Safety and Tolerability of VVD-130850 in Participants With Advanced Solid and Hematologic Tumors (NCT06188208) | Vividion Therapeutics, Inc. | 2024-01-05 |
| A First-in-Human (FIH) Study to Evaluate the Safety and Tolerability of VVD-130037 in Participants With Advanced Solid Tumors (NCT05954312) | Vividion Therapeutics, Inc. | 2023-07-28 |
Track Vividion Therapeutics, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.